Pegylated liposomal doxorubicin in malignant pleural mesothelioma: a possible guardian for long-term survival

Malignant pleural mesothelioma is a rare and aggressive malignancy of the pleura correlated with exposure to asbestos, with a medium survival of 11–12 months after diagnosis. A case of a 67-year-old male who had previously worked in the asbestos industry and is a current smoker is reported. The comp...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Zarogoulidis, Paul, Mavroudi, Maria, Porpodis, Konstantinos, Domvri, Kalliopi, Sakkas, Antonios, Machairiotis, Nikolaos, Stylianaki, Aikaterini, Tsiotsios, Anastasios, Courcoutsakis, Nikolaos, Zarogoulidis, Konstantinos
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2012
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3463410/
https://ncbi.nlm.nih.gov/pubmed/23055748
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S36915
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados